A Trial to Assess the Efficacy and Safety of BioChaperone Combo and Humalog Mix 25 in Subjects With Type 1 Diabetes

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

August 31, 2014

Conditions

DiabetesDiabetes Mellitus, Type 1

Interventions

DRUG

BioChaperone® Combo

Single dose of 0.8U/kg body weight injected subcutaneously (under the skin)

DRUG

Humalog® Mix25

Single dose of 0.8U/kg body weight injected subcutaneously (under the skin)

Trial Locations (1)

Neuss